Zoon Kathryn C 4
4 · Emergent BioSolutions Inc. · Filed May 27, 2020
Insider Transaction Report
Form 4
Zoon Kathryn C
Director
Transactions
- Sale
Common Stock
2020-05-26$85.10/sh−4,093$348,322→ 13,489 total
Footnotes (3)
- [F1]Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- [F2]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
- [F3]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.14 to $86.28.